Health Health News

[Crystal]

The reverse-transcriptase polymerase chain reaction test rates were initially capped at Rs 4,800. While the Supreme Court had directed the tests to be provided freeof-cost in April, the government said it could not implement the order. The state reduced the fee for home collection RT-PCR tests, where all consumables are borne by the laboratory, to Rs 2,000.

Continue reading...

 

[Crystal]

Late last month, AstraZeneca began recruiting 30,000 people in the US for its largest study of the vaccine. It also is testing the vaccine, developed by Oxford University, in thousands of people in Britain, and in smaller studies in Brazil and South Africa.

Continue reading...

 

[Crystal]

The commission has also started framing guidelines for action against substance abuse, a government official said.

Continue reading...

 

[Crystal]

The launch is part of a licensing agreement with Gilead Sciences Inc that grants Dr Reddy's the right to register, manufacture and sell Remdesivir, a potential treatment for COVID-19, in 127 countries including India.

Continue reading...

 

[Crystal]

Russia has reached out to India to seek collaboration of Indian companies in manufacturing vaccines against Covid-19 and also whether phase 3 or bridging studies could be done here. The Centre said there has been significant movement on both the fronts.

Continue reading...

 

[Crystal]

Sushmi Dey, Umesh Isalkar & Rupali Mukherjee India’s central drug regulator Wednesday issued a notice to Pune-based Serum Institute of India (SII), asking why the firm hadn’t informed it about the “reported serious adverse events” that led its UK partner AstraZeneca to “temporarily pause” global

Continue reading...

 

[Crystal]

AstraZeneca said in a statement that as part of the ongoing randomised, controlled clinical trials of the AstraZeneca Oxford coronavirus vaccine, AZD1222, a standard review process has been triggered.

Continue reading...

 

[Crystal]

The declaration by the Pune-based vaccine manufacturer came a day after the Drug Control General of India (DCGI), V.G. Somani, issued a show-cause notice to them asking for an explanation as to why the institute decided to go ahead with the clinical trial of Covid-19 vaccine candidate while doubts about patient safety are yet unclear.

Continue reading...

 

[Crystal]

The proposed agreement also includes an option to purchase an additional 100 million doses of the investigational BNT162 vaccine candidate for member states of the European Union (EU), Xinhua news agency quoted the companies as saying in the statement on Wednesday.

Continue reading...

 

[Crystal]

A record 7,042 cases and 94 deaths were reported in the past 24 hours. This is the largest single day spike in terms of cases and deaths reported so far.

Continue reading...